Comment on “Point‐Of‐Care Testing in Community Pharmacies to Expand Access to Treatment for Sexually Transmitted Infections”

Documenti analoghi

• Clarifying Pharmacy Wholesaler Threshold Limits: Impact on Buprenorphine Access in Rural Communities
  di: Rebecca Lahrman, et al.
  Pubblicazione: (2026)
• Comment on “Consensus Recommendations for the Integration of Critical Care Pharmacists on Intensive Care Unit Teams: Endorsed by the American Association of Critical‐Care Nurses, American College of Clinical Pharmacy, American Society of Health‐System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine”
  di: John Carr, et al.
  Pubblicazione: (2025)
• Response to Comment on “Consensus Recommendations for the Integration of Critical Care Pharmacists on Intensive Care Unit Teams: Endorsed by the American Association of Critical‐Care Nurses, American College of Clinical Pharmacy, American Society of Health‐System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine”
  di: Mojdeh S. Heavner, et al.
  Pubblicazione: (2025)
• An Academic and Health System Partnership to Prepare Practice‐Ready Pharmacy Students for Ambulatory Care Experiences
  di: Autumn Stewart‐Lynch, et al.
  Pubblicazione: (2025)
• A Survey of Hospital Pharmacy Leader Perspectives on Advocating for Clinical Pharmacy Services
  di: Huong Duong, et al.
  Pubblicazione: (2026)